ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
10
views
0
references
Top references
cited by
22
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,633
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES models II workshop.
Author(s):
F Dudek
,
J. P. Stables
,
Brian White
,
Asla Pitkänen
,
Ed Bertram
,
Gary Mathern
,
Greg Holmes
Publication date:
2003-11-30
Journal:
Epilepsia
Keywords:
Animals
,
Anticonvulsants
,
therapeutic use
,
Chronic Disease
,
Disease Models, Animal
,
Drug Resistance
,
Epilepsy
,
drug therapy
,
etiology
,
prevention & control
,
Humans
,
National Institutes of Health (U.S.)
,
Status Epilepticus
,
United States
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free pdf)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
ChemSpider related publications
Author and article information
Journal
PubMed ID::
14636315
DOI::
10.1111/j.0013-9580.2003.32803.x
ScienceOpen disciplines:
Chemistry
Keywords:
Animals
,
Anticonvulsants
,
therapeutic use
,
Chronic Disease
,
Disease Models, Animal
,
Drug Resistance
,
Epilepsy
,
drug therapy
,
etiology
,
prevention & control
,
Humans
,
National Institutes of Health (U.S.)
,
Status Epilepticus
,
United States
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Animals
,
Anticonvulsants
,
therapeutic use
,
Chronic Disease
,
Disease Models, Animal
,
Drug Resistance
,
Epilepsy
,
drug therapy
,
etiology
,
prevention & control
,
Humans
,
National Institutes of Health (U.S.)
,
Status Epilepticus
,
United States
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,633
Successful treatment of pharmacoresistent continuous spike wave activity during slow sleep with levetiracetam.
Authors:
Thomas Hoppen
,
Manfred Rister
,
Torsten Sandrieser
P02.5 Lamotrigine monotherapy for pharmacoresistant complex partial seizures in children with hippocampal atrophy
Authors:
D. Chkhartishvili
,
G. Natriashvili
Long-term experience with fractionated stereotactic radiotherapy in pharmacoresistant epilepsy: Neurological and MRI changes
Authors:
Christophe Rauch
,
Sabine Semrau
,
Rainer Fietkau
…
See all similar
Cited by
22
Opportunities for improving animal welfare in rodent models of epilepsy and seizures
Authors:
Katie Lidster
,
John G. Jefferys
,
Ingmar Blümcke
…
The effects of carbamazepine in the intrahippocampal kainate model of temporal lobe epilepsy depend on seizure definition and mouse strain
Authors:
Friederike Twele
,
Kathrin Töllner
,
Marion Bankstahl
…
Pathogenesis of Epilepsy: Challenges in Animal Models
Authors:
Yow Hui Yin
,
Nurulumi Ahmad
,
Mohd Makmor-Bakry
See all cited by